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Abstract
Objective: Cardiac resynchronization therapy is proven efficacious in patients with heart failure (HF). Presence of
biventricular HF is associated with a worse prognosis than having only left ventricular (LV) HF and pacing might
deteriorate heart function. The aim of the study was to assess a possible significance of right ventricular (RV) pre-
implant systolic function to predict response to CRT.
Design: We studied 22 HF-patients aged 72 ± 11 years, QRS-duration 155 ± 20 ms and with an LV ejection
fraction (EF) of 26 ± 6% before and four weeks after receiving a CRT-device.
Results: There were no changes in LV diameters or end systolic volume (ESV) during the study. However, end
diastolic volume (EDV) decreased from 226 ± 71 to 211 ± 64 ml (p = 0.02) and systolic maximal velocities (SMV)
increased from 2.2 ± 0.4 to 2.6 ± 0.9 cm/s (p = 0.04). Pre-implant RV-SMV (6.2 ± 2.6 cm/s) predicted postoperative
increase in LV contractility, p = 0.032.
Conclusions: Pre-implant decreased RV systolic function might be an important way to predict a poor response to
CRT implicating that other treatments should be considered. Furthermore we found that 3D- echocardiography
and Tissue Doppler Imaging were feasible to detect short-term changes in LV function.
Background
Chronic heart failure (CHF) is a frequent cause of in-
hospital health care with a high cost. These patients
have a poor quality of life (QoL) and a high readmission
rate despite drugs such as RAAS- and beta-blockers,
diuretics and aldosterone-antagonists which all have
positive prognostic effects [1-5].
Cardiac Resynchronization Therapy (CRT) is estab-
lished as an effective therapy to reduce mortality and
morbidity in patients with systolic heart failure (HF) and
prolonged QRS in functional class (NYHA) III-IV despite
optimal medical treatment [6-10].
Dyssynchrony was pointed out as a baseline predictor
of a beneficial effect of CRT in an analysis of the PRO-
SPECT trial [11,12]. The analysis also pointed out other
important baseline predictors of a beneficial response to
CRT such as female gender, non-ischemic ethiology,
NYHA-class III, QRS-duration and no history of ventri-
cular tachycardia. NYHA-class IV was not associated
with CRT response and one reason might be that right
ventricular (RV) apical pacing sometimes deteriorates LV
function [13,14] and many NYHA-class IV HF patients
have RV dysfunction. The pathophysiologic explanations
are not known for sure but could, at least partly, be that
an already injured RV cannot manage the increased pre-
load caused by better LV function in some patients. In
the MADIT II trial it was found that patients receiving
RV pacing had an increased prevalence of worsened
heart failure than those with less RV pacing (15).
Aims
We assessed whether pre-implant systolic RV function
could predict short-term response to CRT and if 3D- and
TDI-echocardiography could be used to detect early
changes in LV dimensions and function.
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Study Population
We enrolled 22 consecutive HF patients fulfilling stan-
dard criteria for CRT. All patients had a reduced systolic
left ventricular (LV) function with an ejection fraction
(EF) below 35%, QRS - duration > 120 ms and NYHA
class III-IV despite optimal medical treatment (table 1).
Exclusion criterion was atrial fibrillation.
All patients gave informed consent. The study adhered
to the Helsinki declaration and was approved by the
Regional Ethical Review Board.
Echocardiography and Tissue Doppler Imaging
The patients were examined in the left lateral position
and Tissue Doppler Imaging (TDI) echocardiography was
acquired in three apical views using the Vivid 7 or 5 (the
later for 3-D echocardiography only) systems (Vingmed,
Hortem, Norway), with a 2.5 MHz probe. Three consecu-
tive beats were registered and mean values were used for
further analysis. Analyses were made off-line (Echo-Pac
software, Hortem, Norway). The 16 segments LV-model
of the American Society of Echocardiography was used
for orientation [16]. Base and mid LV-segments, a total
of 12, were used together with base and mid RV-seg-
ments in the 4-chamber view. The LV end diastolic
dimension (LVEDd) was measured in the parasternal
long axis (PLAX) view from 2D registrations. The LV
end systolic diameter (LVESd) was measured in the same
view with the smallest achievable LV size. Regional systo-
lic contractility was assessed as systolic maximal velocity
(SMV) during the ejection phase in the same segments.
Tissue tracking (TT) was used to measure the
longitudinal function in each segment. A mean value for
12 LV segments was calculated to achieve a measurement
of global contractility.
Trans thoracic 3D Echo was performed using a 2.5 MHz
transducer mounted in a handheld rotation device. The
cardiac images were recorded from the apex during end-
expiratory apnoea within one breath hold, whereby the
need for respiratory triggering was abolished as previously
described [17]. End diastolic volume (EDV) and End systo-
lic volume (ESV) were measured and ejection fraction (EF)
was calculated by the formula EDV-ESV/EDV × 100. All
examinations were performed before and four weeks after
receiving the CRT-device and stored for later off-line ana-
lysis. Volumes measured by 3D echo are almost as sensi-
tive as measured by Magnetic Resonance Imaging. Thus,
we used a combination of echo methods since we believe
that they are enough sensitive to detect changes during
short-term follow-up.
Biventricular Pacemaker Implantation
All patients received a CRT device (Insync III
®,M e d -
tronic) implanted transvenously as described previously
[17].
Statistical analyses
Continuous variables with a normal distribution were ana-
l y z e db yp a i r e dS t u d e n t st - t e s ta n dg i v e na sm e a n±S D .
Other variables were analyzed by nonparametric tests and
data are given as medians and range. All analyses were
performed by Statistica
® version 9.1 software (StatSoft,
Inc., Tulsa, USA). Multivariable regression was performed
by the best subset technique of Statistica. The ability of
the right ventricular function variables to explain change
in left ventricular function was the main analysis. The
robustness of the variables to predict this change was also
tested by using variable importance (VIP) in a Projection
to Latent Structures (PLS)-regression analysis. We
regarded p < 0·05 (two-sided) as significant.
Results
Baseline characteristics of the patients are presented in
table 1. Clinical and conventional, 3D and TDI echocar-
diographic changes from before to four weeks after CRT
implantation are shown in table 2.
There were no changes in LV diameters or ESV. How-
ever, EDV decreased from 226 ± 71 to 211 ± 64 ml (p =
0.02) and SMV increased from 2.2 ± 0.4 to 2.6 ± 0.9 cm/s
(p = 0.04). The increase in LV-SMV could by 41%
(adjusted R
2 in best subset multiple regression) be
explained by pre-implant RV-SMV and RV-TT. These
two variables were also shown to be the most important
predictor variables in a PLS regression. Inclusion of pre-
implant LV-SM and LV-TT in the multivariable regression
did not improve the explanation of the change in LV-SM
Table 1 Baseline characteristics (n = 22)
Variable HF patients
Age (years) 72 ± 11 (47-88)
Gender (male) 20
Heart Rate, bpm
QRS-width, ms
69 ± 18 (45-129)
155 ± 20 (120-190)
Function Class, NYHA (n)
III 20
IV 2
Previous Myocardial Infarction 11
Hypertension 3
Dilated Cardiomyopathy 4
Diabetes 3
ACE/ARB 22
Diuretics 22
Beta-blockers 19
Spironolactone 15
Mean ± SD unless otherwise stated. HF = heart failure, NYHA = New York
Heart Association,
ACEi = Angiotensin Converter Enzyme Inhibitor, ARB = Angiotensin Receptor
Blocker.
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was no longer significant.
Discussion
We found that pre-implant RV systolic function as
assessed by TDI could predict short-term response to
CRT. The results are plausible from a mechanistic point of
view but should of course be reproduced in a larger cohort
of patients and with a longer follow-up.
The clinical implication of a role of pre-implant systolic
RV function in the response to CRT should of course be
that other treatments than CRT should be considered in
patients with severe RV HF.
Our findings are supported by others using other meth-
ods and longer follow-up to study the importance of pre-
implant RV systolic function [18,19]. Scuteri et al used an
extensive echo-Doppler examination and found that pre-
implant M-mode (TAPSE), RV systolic pressure mea-
sured by Doppler, RV dimensions and RV area change to
be related with post-implant LV ESV remodelling [18].
They also found these relations to be consistent indepen-
dent of aetiology and degree of dyssynchrony indicating
the important roll of the pre-implant RV function. They
suggest TAPSE < 14 mm, a simple and highly reproduci-
ble method, as cut-off value to define advanced RV dys-
function and found this cut-off to be associated with a
twofold risk of the combined end point of death and
emergency heart transplantation. In another study by
Tabereaux et al a visual grading by 2D echocardiography
of the RV function was used [19]. RV EF < 40% was the
definition of RV systolic dysfunction and found to be
associated to less response to CRT during 6 month’sf o l -
low-up. Thus, the importance of preserved pre-implant
systolic RV function has been demonstrated by different
methods in HF patients with standard indication for
CRT.
A suggested echocardiographic cut-off value of response
t oC R Ti sa nd e c r e a s eb ya p p r o x i m a t e l y1 0 %i nt h ee n d
Table 2 Clinical and Echocardiographic (conventional, 3D and TDI) changes from pre-implantation to four weeks after
CRT implantation
Variable Pre-
implantation
Four weeks after
CRT-implantation
p-value
QRS, ms 155 ± 20 162 ± 29 n.s.
NT-proBNP, pg/ml 2925 ± 2611 3290 ± 3545 n.s.
Minnesota-score, median(range) 49 (11-90) 30 (1-69) 0.0004
NYHA-class, median(range) 3 (2-4) 2 (1-3) 0.0064
LV EDd, mm 67.6 ± 9.2 67.4 ± 8.9 n.s.
LV ESd, mm 59.2 ± 10.1 59.3 ± 9.9 n.s.
MR, 0-4, median(range) 1.5(0.5-2.5) 1.0(0.0-2.5) 0.063
LV EDV, ml 226 ± 71 211 ± 64 0.020
LV ESV, ml 169 ± 64 163 ± 59 n.s.
EF, % 24 ± 7 24 ± 8 n.s.
Ts septum-lateral, ms 60 ± 31 52 ± 44 n.s.
LV TT, mm 3.1 ± 1.2 3.9 ± 1.5 0.038
LV SMV, cm/s 2.2 ± 0.4 2.6 ± 0.9 0.045
RV TT, mm 8.8 ± 4.8 9.4 ± 3.7 n.s.
RV SMV, cm/s 6.2 ± 2.6 6.5 ± 2.6 n.s.
Mean ± SD unless otherwise stated. MR = mitral regurgitation, Ts = dyssynchrony, SMV = systolic maximal velocity, LV EDd = left ventricular end diastolic
diameter, LV ESd = left ventricular end systolic diameter, EF = ejection fraction. EDV = end diastolic volume, ESV = end systolic volume, TT = tissue tracking, RV =
right ventricular.
Table 3 Results of multivariable regression of the influence of pre-implant RV-SM, RV-TT, LV-SM and LV-TT on change
in LV-SM four weeks after CRT implantation
Parameter 95.00% Confidence interval p-value Beta-value
Intercept 0.067 (-1.74-1.87) 0.94
RV SM 0.25 (0.024-0.47) 0.032 0.85
RV TT -0.13 (-0.31-0.05) 0.15 -0.59
LV SMV -0.18 (-1.46-1.10) 0.77 -0.10
LV TT -0.01 (-0.53-0.51) 0.97 -0.014
RV = right ventricular, LV = left ventricular, SMV = systolic maximal velocity, TT = tissue tracking.
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after 12 weeks CRT and there are no certain parameters
to be measured to define a response already after four
weeks of CRT. Thus, in this study we chose a combination
of clinical parameters such as patient-assessed functional
class and quality of life and echocardiographic parameters
such as LV diameters (conventional echo), LV volumes
(3D echo) and myocardial velocities and longitudinal
movement (TDI) to decide whether there where a
response after four weeks of CRT or not. According to
this approach 68% of the patients responded to CRT in
this study, which main aim however was to assess the
importance of the pre-implant systolic RV function. 3D
echo has been reported almost as sensitive as magnetic
resonance imaging when measuring LV volumes and Mül-
ler-Brunotte at al reported TDI to be more sensitive than
conventional echo measuring effects after treatment of
hypertension induced LV hypertrophy [22]. It seems
obvious that echocardiography should be used more when
planning or doing follow-up in CRT since a lot of impor-
tant information is given. However, the technique requires
time and special interest and if it has to be done in all
patients it might result in underuse of the CRT, a very
effective treatment which probably is underused already
today.
One explanation to the suggested importance of pre-
implant systolic RV function might be a preload increase
caused either by an acute deterioration in RV systolic
function or by a miss match improvement where the LV
function improves more than the RV function resulting
in non-responding to CRT.
Furthermore, in the revised ESC guidelines on device
therapy in HF it is pointed out that conventional pacing
might increase symptoms and deteriorate LV function and
therefore biventricular pacing is recommended regardless
of QRS prolongation in patients with LV dysfunction and
signs of HF [23].
In conclusion our findings implicate that pre-implant
RV systolic function might be an important predictor of
the poor response to CRT in some patients with biventri-
cular heart failure and other treatments should be consid-
ered in these patients. Furthermore 3D- echocardiography
and TDI seem feasible to detect changes in LV function
during short-term follow-up.
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